Client News

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

AFFiRiS announces Phase 2 study in Parkinson’s and new focus on neurodegenerative diseases

InflaRx to Present at Upcoming J.P. Morgan Annual Healthcare Conference

InfanDx receives U.S. patent for its core technology on diagnosis of neonatal encephalopathy

Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA

Karl Naegler joins Wellington Partners as Managing Partner

Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction

MagForce AG announces successful capital increase of the subsidiary MagForce USA, Inc.

Vivoryon Therapeutics is Included in AScX Index

Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG